As expected, DN-vehicle mice developed robust progressive albuminuria (expressed as urinary albumin to creatinine ratio (ACR)) and AS-IV prevented the development of diabetes-induced albuminuria in a dose-dependent manner (Fig. 1A) without altering the blood glucose levels and body weight (Table 1). This evidence concerns the gene ALB and diabetes mellitus.